Wu, Y., Sreeharsha, N., Sharma, S., Mishra, A., Singh, A. K., & Gubbiyappa, S. K. (2020). Anticancer Effect of Rosiglitazone, a PPAR‑γ Agonist against Diethylnitrosamine-Induced Lung Carcinogenesis. American Chemical Society.
Cita Chicago Style (17a ed.)Wu, Yanqiao, Nagaraja Sreeharsha, Sanjay Sharma, Anurag Mishra, Avinash Kumar Singh, y Shiva Kumar Gubbiyappa. Anticancer Effect of Rosiglitazone, a PPAR‑γ Agonist Against Diethylnitrosamine-Induced Lung Carcinogenesis. American Chemical Society, 2020.
Cita MLA (8a ed.)Wu, Yanqiao, et al. Anticancer Effect of Rosiglitazone, a PPAR‑γ Agonist Against Diethylnitrosamine-Induced Lung Carcinogenesis. American Chemical Society, 2020.
Precaución: Estas citas no son 100% exactas.